AIDS News and Research

RSS

Biomagnetics Diagnostics receives commitment for clinical validation testing in India for malaria, TB diagnosis

Biomagnetics Diagnostics Corp., a developer of revolutionary diagnostic systems and technology for HIV, hepatitis, tuberculosis and malaria detection, today announced it has received important commitments from two leading research laboratories in India for clinical validation testing for malaria and tuberculosis (TB) detection and diagnosis.

21 Apr 2010

New self-referencing glutamate biosensor to measure glutamate flux of neural cells in living organism

A new biosensor developed at Purdue University can measure whether neurons are performing correctly when communicating with each other, giving researchers a tool to test the effectiveness of new epilepsy or seizure treatments.

21 Apr 2010

Hearing tests needed for children

The importance of hearing testing isn't widely understood by many parents. Parents may schedule appointments with an opthamologist for an eye exam for their children at regular intervals - but never think to similarly schedule a hearing test with an audiologist.

21 Apr 2010

Lotus Pharmaceuticals' asthma drug Laevo-Bambutero to receive Chinese SFDA Fast Track Approval

Lotus Pharmaceuticals, Inc., a growing developer, manufacturer and seller of medicine and drugs in the People's Republic of China reported that its asthma drug Laevo-Bambutero will receive the China's State Food & Drug Administration's (SFDA) Fast Track Approval to enter clinical trials. The SFDA's Drug Review and Evaluation Center told the Company during recent consultations at the end of the Company's IND that formal approval would be granted by the Beijing office of the SFDA.

21 Apr 2010

Report details progress in fighting malaria in Africa, notes funding shortfall

Global funding for malaria reached $1.7 billion in 2009, a "ten-fold" increase since 2004, and the production of insecticide-treated nets (ITNs) worldwide rose to 150 million last year, according to a report, released Monday, from UNICEF and the Roll Back Malaria (RBM) partnership, which also highlighted the need for additional funding, Agence France-Presse reports (4/19).

21 Apr 2010

Cochlear implantation improves comprehension and spoken language expression in children under 5

Children under 5 years of age with severe hearing loss who underwent cochlear implantation experienced greater improvement in comprehension and expression in spoken language than would be predicted from their pre-implantation language scores, with younger age at implantation associated with greater improvements, according to a study in the April 21 issue of JAMA.

21 Apr 2010

A Selection of Today's Opinions: AIDS endures; Conservatives' changing views of the individual mandate; Concerns for doctors

AIDS endures right here in the U.S.A.: our outpatient clinics are bursting at the seams, and new cases show up daily. A million domestic stories are languishing untold, but they are not the operatic tragedies we have grown used to (Dr. Abigail Zuger, 4/19).

21 Apr 2010

AHRQ report shows highest hospital readmission rates among Medicaid patients

One of every 10 adult Medicaid patients who were hospitalized in 2007 for a medical condition other than childbirth had to be readmitted at least once within 30 days of their initial hospital stay that year, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.

20 Apr 2010

New report studies healthcare market in Europe and provides insights, analysis up to 2014

Healthcare has always been an area of utmost importance. It has significant economic relevance and has been allocated a higher percent of gross domestic product in many countries compared to most other sectors such as transport and communication, construction and education. Healthcare also has a huge impact on employment, for the fact that most related activities are provided by people.

20 Apr 2010

Opinions: PEPFAR; Private-civil society partnerships in Africa; Global maternal mortality; SA HIV testing campaign

"The Obama administration's new Global Health Initiative, designed to broaden and better integrate health programming overseas, deserves wide support. But stalling on global AIDS threatens to undermine the worthy goals of the initiative," Chris Collins, vice president and director of public polity for the Foundation for AIDS Research, writes in a Boston Globe letter to the editor calling for sustained support for PEPFAR.

20 Apr 2010

Viral Genetics relocates research facilities to Georgetown

Biotech company Viral Genetics, Inc.,, is relocating its research facilities to the life science cluster in Georgetown, Texas. Lead scientist Dr. Karen Newell has joined the faculty of Texas A&M University's College of Medicine and has received a $750,000 grant to research bio-fuels from the Texas Emerging Technology Fund.

20 Apr 2010

New research shows link between infection-related diseases and risk of cancer

New research is emerging that suggests a link between infection-related diseases and risk of cancer, according to findings presented here at the American Association for Cancer Research 101st Annual Meeting 2010.

20 Apr 2010

Matrix Laboratories' ANDA for Didanosine Delayed-release Capsules receives FDA approval under PEPFAR

Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has received final approval from the U.S. Food and Drug Administration (FDA) under the President's Emergency Plan for AIDS Relief (PEPFAR) for its Abbreviated New Drug Application (ANDA) for Didanosine Delayed-release Capsules, 125 mg, 200 mg, 250 mg and 400 mg, the generic version of Bristol Myers Squibb's HIV treatment Videx® EC.

19 Apr 2010

Health insurance roundup: N.Y.'s high costs, COBRA concerns, high-risk pools

News outlets are covering various aspects of the health insurance industry, especially in light of health reform.

19 Apr 2010

RSCRC scientists explore mysteries of human embryonic stem cells

At Rutgers' Stem Cell Research Center scientists are exploring the mysteries of human embryonic stem cells and their potential use in treating diseases, repairing damaged organs, and drug development. Center staff also offer a course in proper lab techniques in working with stem cells.

17 Apr 2010

Intensive rehabilitation therapy with robotic aids can help stroke patients regain limb movement

Patients show modest yet meaningful gains in limb movement and an improved outlook on life years after suffering a stroke, a major clinical study has found. The paper, published online this week in the New England Journal of Medicine, provides the best evidence yet that stroke sufferers in a controlled study can regain limb movement long after an injury, through intensive therapy with specially trained personnel and newly created robotic aids.

17 Apr 2010

GeoVax Labs Labs announces 1-for-50 reverse stock split

GeoVax Labs, Inc., a biotechnology company that creates, develops, and tests innovative HIV/AIDS vaccines, today announced it will implement a 1-for-50 reverse stock split effective following the close of business on April 27, 2010. After the reverse stock split, the Company will be authorized to issue up to 40 million shares of stock, of which approximately 15.7 million shares will be outstanding.

17 Apr 2010

Strativa Pharmaceuticals: Oravig buccal tablets receive FDA approval for OPC

Strativa Pharmaceuticals today announced that the U.S. Food and Drug Administration has approved Oravig (miconazole) buccal tablets for the treatment of oropharyngeal candidiasis, more commonly known as thrush, in adults and children age 16 and older.

17 Apr 2010

FDA approves BioAlliance Pharma's Oravig for OPC

BioAlliance Pharma SA, a company dedicated to the treatment and supportive care of cancer and AIDS patients, announces today the approval by the US FDA of Oravig® (miconazole Lauriad®, known as Loramyc® in Europe) for the treatment of Oropharyngeal Candidiasis (OPC) in adults.

17 Apr 2010

Results from Romark Laboratories' STEALTH C-3 clinical trial presented at EASL Annual Meeting

Romark Laboratories announced results from its STEALTH C-3 clinical trial, a phase 2 clinical study of nitazoxanide in treatment-naive patients with genotype 1 chronic hepatitis C. Study results were presented as a late breaking communication at the International Liver Congress™ 2010, the 45th Annual Meeting of the European Association for the Study of the Liver in Vienna, Austria.

16 Apr 2010

AIDS News and Research

Biomagnetics Diagnostics receives commitment for clinical validation testing in India for malaria, TB diagnosis

New self-referencing glutamate biosensor to measure glutamate flux of neural cells in living organism

Hearing tests needed for children

Lotus Pharmaceuticals' asthma drug Laevo-Bambutero to receive Chinese SFDA Fast Track Approval

Report details progress in fighting malaria in Africa, notes funding shortfall

Cochlear implantation improves comprehension and spoken language expression in children under 5

A Selection of Today's Opinions: AIDS endures; Conservatives' changing views of the individual mandate; Concerns for doctors

AHRQ report shows highest hospital readmission rates among Medicaid patients

New report studies healthcare market in Europe and provides insights, analysis up to 2014

Opinions: PEPFAR; Private-civil society partnerships in Africa; Global maternal mortality; SA HIV testing campaign

Viral Genetics relocates research facilities to Georgetown

New research shows link between infection-related diseases and risk of cancer

Matrix Laboratories' ANDA for Didanosine Delayed-release Capsules receives FDA approval under PEPFAR

Health insurance roundup: N.Y.'s high costs, COBRA concerns, high-risk pools

RSCRC scientists explore mysteries of human embryonic stem cells

Intensive rehabilitation therapy with robotic aids can help stroke patients regain limb movement

GeoVax Labs Labs announces 1-for-50 reverse stock split

Strativa Pharmaceuticals: Oravig buccal tablets receive FDA approval for OPC

FDA approves BioAlliance Pharma's Oravig for OPC

Results from Romark Laboratories' STEALTH C-3 clinical trial presented at EASL Annual Meeting

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News